FDA seeks input on biomarker development

FDA is seeking comments on how to facilitate the development and qualification of biomarkers for therapeutics. The agency has created a survey to gather information on specific aspects of drug development and disease areas that could benefit most from new biomarkers. Comments are due April 14. ...